Cargando…

COVID-19 vaccines surveillance in France: a global response to a major national challenge

Detalles Bibliográficos
Autores principales:	Benkebil, Mehdi, Gautier, Sophie, Gras-Champel, Valérie, Massy, Nathalie, Micallef, Joelle, Valnet Rabier, Marie-Blanche
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061787/ https://www.ncbi.nlm.nih.gov/pubmed/33895471 http://dx.doi.org/10.1016/j.accpm.2021.100866

Ejemplares similares

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
por: Valnet-Rabier, Marie-Blanche, et al.
Publicado: (2023)

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
por: Gras-Champel, Valérie, et al.
Publicado: (2021)

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level
por: Chouchana, Laurent, et al.
Publicado: (2021)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
por: Toussirot, Éric, et al.
Publicado: (2013)

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
por: Moulis, Guillaume, et al.
Publicado: (2022)

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023)

Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France
por: Adopo, D., et al.
Publicado: (2022)

Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)
por: Laroche, Marie‐Laure, et al.
Publicado: (2022)

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database
por: Thai-Van, Hung, et al.
Publicado: (2023)

Comprehensive description of adult-onset Still's disease after COVID-19 vaccination
por: Palassin, Pascale, et al.
Publicado: (2023)

COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance
por: Massy, Nathalie, et al.
Publicado: (2023)

Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
por: Tambon, Marine, et al.
Publicado: (2021)

Addictovigilance contribution during COVID-19 epidemic and lockdown in France
por: Lapeyre-Mestre, Maryse, et al.
Publicado: (2020)

Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
por: Martin, Guillaume L., et al.
Publicado: (2022)

Risk factors for and characteristics of community‐ and hospital‐acquired drug‐induced acute kidney injuries
por: Rey, Amayelle, et al.
Publicado: (2022)

Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review
por: Bertrand, Valérie, et al.
Publicado: (2021)

Global Surveillance, National Surveillance, and SARS
por: Heymann, David L., et al.
Publicado: (2004)

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease
por: Turco, Célia, et al.
Publicado: (2015)

Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
por: Létinier, Louis, et al.
Publicado: (2021)

Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation
por: Batteux, Benjamin, et al.
Publicado: (2020)

Mycoplasmoses of ruminants in France: recent data from the national surveillance network
por: Chazel, Myriam, et al.
Publicado: (2010)

Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
por: Roussin, Anne, et al.
Publicado: (2022)

Human and animal botulism surveillance in France from 2008 to 2019
por: Le Bouquin, Sophie, et al.
Publicado: (2022)

Implementation of a national waterborne disease outbreak surveillance system: overview and preliminary results, France, 2010 to 2019
por: Pouey, Jerome, et al.
Publicado: (2021)

Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet
por: Azar, Christine, et al.
Publicado: (2021)

Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
por: Rey, Amayelle, et al.
Publicado: (2019)

A predominantly left-sided skin reaction to pristinamycin in a patient with right hemiplegia
por: Delcroix, Fanny, et al.
Publicado: (2016)

Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists
por: Liabeuf, Sophie, et al.
Publicado: (2016)

Use of medical administrative data for the surveillance of psychotic disorders in France
por: Chan Chee, Christine, et al.
Publicado: (2017)

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation
por: Marienne, Justine, et al.
Publicado: (2020)

SARS-CoV-2 testing, infection and places of contamination in France, a national cross-sectional study, December 2021
por: Vaux, Sophie, et al.
Publicado: (2023)

Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase(®))
por: Dernoncourt, Amandine, et al.
Publicado: (2022)

Medication Sales and Syndromic Surveillance, France
por: Vergu, Elisabeta, et al.
Publicado: (2006)

Recent developments in particle identification
por: Benkebil, M
Publicado: (1997)

Infection of Wildlife by Mycobacterium bovis in France Assessment Through a National Surveillance System, Sylvatub
por: Réveillaud, Édouard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1fpfefh5ckpr28c73o7u3dmipf